search

Active clinical trials for "Hemorrhage"

Results 1941-1950 of 2870

Trial of HoLEP vs. PVP in Treating BPH in Patients With Bleeding Tendency

Benign Prostatic Hyperplasia

Patients presented for BPH surgery at our out patient clinic will be assessed for abnormal bleeding profile. Patients with bleeding tendency will be offered either HoLEP or Greenlight laser PVP based on prostate size cut off point of 80ml Larger prostates will be treated with HoLEP Smaller prostates will be treated with greenlight PVP

Unknown status8 enrollment criteria

Comparison of the Effects of Gelatine Versus Balanced Crystalloid Solution for Volume Therapy

HemorrhageSurgical3 more

The purpose of the study is to determine whether volume therapy with a solution of gelatine has negative impact on coagulation, platelet function, renal function in comparison with crystaloid solution (Ringerfundin).

Unknown status14 enrollment criteria

Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Volunteers During a Blood Draw

Blood Loss

To determine if a manual blood loss can be detected using the non-invasive blood monitor.

Completed9 enrollment criteria

Endoscopic Treatment of Recurrent Upper GI Bleeding: OTSC [Over the Scope Clip] Versus Standard...

Acute Upper Gastrointestinal Hemorrhage

Prospective-randomized trial. Patients with recurrent bleeding from gastroduodenal ulcers are randomized into either endoscopic treatment with the OTSC [Over The Scope Clip] or endoscopic standard therapy. Hypothesis: Endoscopic therapy with OTSC is superior to standard therapy regarding technical success and rebleeding.

Unknown status2 enrollment criteria

Surgical Trial in Lobar Intracerebral Haemorrhage

Intracerebral Haemorrhage

To establish whether a policy of earlier surgical evacuation of the haematoma in selected patients with spontaneous lobar ICH will improve outcome compared to a policy of initial conservative treatment. The trial will also help to better define the indications for early surgery. This will overcome two of the criticisms of STICH (timing was too late and sometimes location was too deep). The subgroup identified in STICH is clinically sensible and the hypothesis identified for STICH II is in line with current neurosurgical opinion.

Unknown status11 enrollment criteria

Prophylactic Injection Therapy Reduces Recurrent Bleeding In Forrest Type IIb Duodenal Ulcers

Duodenal Ulcer Bleeding

The purpose of this study is to determine whether prophylactic injection therapy reduces recurrent bleeding rate for duodenal ulcers which has the endoscopic stigmata of recent bleeding.

Completed6 enrollment criteria

Does Early Re-administration of Aspirin/Clopidogrel Increase the Risk of Bleeding From Artificial...

Early Gastric CancerGastric Dysplasia

Aspirin and/or clopidogrel users are increasing due to increased prevalence of cardiovascular or cerebrovascular disease with an aging society in Korea. Also, the patients having endoscopic mucosal resection (EMR) or endoscopic submucosal dissection (ESD) for early gastric cancer or gastric premalignant lesions including adenoma and dysplasia are increasing among aspirin and/or clopidogrel users. Practically, aspirin or clopidogrel is recommended to be stopped for 5~14 days before EMR or ESD because bleeding risk during or after procedure. And it is recommended to restart of aspirin and/or clopidogrel as soon as possible if immediate bleeding during or after the procedure is not occurred in consideration of thromboembolic risk. However, early restarting of aspirin and/or clopidogrel raise the risk of delayed bleeding and the risk of complications associated with delayed ulcer healing. Although it is important to determine the timing of restarting aspirin and/or clopidogrel in consideration of complications of post-EMR/ESD ulcer and thromboembolic risk, there is no definite guideline about the timing of restarting aspirin and/or clopidogrel. This study is aimed to determine the timing of restarting aspirin and/or clopidogrel for the patients having EMR or ESD among aspirin and/or clopidogrel users. The investigators planned to compare the delayed bleeding rate and ulcer healing rate in patients with post-EMR/ESD ulcer when take proton pump inhibitor (pantoprazole 40 mg per day) between the patients restarting aspirin and/or clopidogrel within 3~4 days after the procedure and the patients restarting aspirin and/or clopidogrel 2 weeks after the procedure during 4 weeks. The primary endpoint is delayed ulcer bleeding rate at 4 weeks after EMR/ESD. The secondary end point is ulcer healing rate within 4 weeks.

Unknown status7 enrollment criteria

Trial of Argon Plasma Coagulation Versus APC and APC and Hemospray in the Treatment of Radiation...

Rectal Bleeding

Randomized trial of Argon Plasma Coagulation compared with Argon Plasma Coagulation and Hemospray in the therapy of bleeding from Radiation Proctitis

Unknown status2 enrollment criteria

Comparison of the Frequency-altering AKE-1 Capsule and Pillcam SB2

Intestinal DiseasesGastrointestinal Hemorrhage

Capsule endoscopy has been shown to be the first-line endoscopic procedure for small bowel disease. This study was aimed to compare the performance between the frequency-altering AKE-1 capsule and the Pillcam SB2 in patients with suspected small bowel disease.

Completed6 enrollment criteria

The Effect of Human Albumin on Coagulation Competence and Hemorrhage

Hemorrhage; Complicating DeliveryCoagulation Defect

In a randomized clinical trial, the purpose is to investigate if perioperative coagulation and hemorrhage is influenced by colloid or crystalloid.

Unknown status10 enrollment criteria
1...194195196...287

Need Help? Contact our team!


We'll reach out to this number within 24 hrs